NEW YORK (GenomeWeb) – GeneNews reported today a doubling of its first quarter revenues, and announced that it has signed a US partnership agreement for its portfolio of early cancer detection tests with lab testing services provider Any Lab Test Now (ALTN).

For the three-month period ended March 31, GeneNews' revenues climbed to $200,000 from $100,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.